Group One Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-200
| Closed | -$140 | – | 8266 |
|
|
2023
Q4 | $140 | Hold |
200
| – | – | ﹤0.01% | 7184 |
|
|
2023
Q3 | $137 | Hold |
200
| – | – | ﹤0.01% | 7455 |
|
|
2023
Q2 | $478 | Buy |
+200
| New | +$854 | ﹤0.01% | 7375 |
|
|
2022
Q2 | – | Sell |
-21
| Closed | -$1K | – | 8752 |
|
|
2022
Q1 | $1K | Sell |
21
-495
| -96% | -$21.2K | ﹤0.01% | 7910 |
|
|
2021
Q4 | $22K | Sell |
516
-245
| -32% | -$15.3K | ﹤0.01% | 6935 |
|
|
2021
Q3 | $52K | Sell |
761
-2,598
| -77% | -$190K | ﹤0.01% | 6521 |
|
|
2021
Q2 | $259K | Buy |
3,359
+1,589
| +90% | +$96.8K | ﹤0.01% | 4947 |
|
|
2021
Q1 | $116K | Buy |
+1,770
| New | +$138K | ﹤0.01% | 5528 |
|
|
2019
Q4 | – | Sell |
-114
| Closed | -$6K | – | 5759 |
|
|
2019
Q3 | $6K | Sell |
114
-526
| -82% | -$37.8K | ﹤0.01% | 4739 |
|
|
2019
Q2 | $58K | Sell |
640
-351
| -35% | -$42.7K | ﹤0.01% | 3699 |
|
|
2019
Q1 | $146K | Sell |
991
-648
| -40% | -$125K | ﹤0.01% | 2920 |
|
|
2018
Q4 | $258K | Sell |
1,639
-374
| -19% | -$71.7K | ﹤0.01% | 2489 |
|
|
2018
Q3 | $493K | Buy |
2,013
+1,827
| +982% | +$433K | ﹤0.01% | 2297 |
|
|
2018
Q2 | $42K | Sell |
186
-157
| -46% | -$42K | ﹤0.01% | 4049 |
|
|
2018
Q1 | $84K | Sell |
343
-81
| -19% | -$21.3K | ﹤0.01% | 3356 |
|
|
2017
Q4 | $131K | Buy |
424
+250
| +144% | +$82.2K | ﹤0.01% | 3200 |
|
|
2017
Q3 | $64K | Sell |
174
-456
| -72% | -$162K | ﹤0.01% | 3504 |
|
|
2017
Q2 | $229K | Buy |
630
+557
| +763% | +$167K | ﹤0.01% | 2553 |
|
|
2017
Q1 | $22K | Buy |
+73
| New | +$18.4K | ﹤0.01% | 3844 |
|
|
2016
Q4 | – | Sell |
-234
| Closed | -$56K | – | 4933 |
|
|
2016
Q3 | $56K | Buy |
234
+71
| +44% | +$14.8K | ﹤0.01% | 3290 |
|
|
2016
Q2 | $32K | Buy |
+163
| New | +$75.1K | ﹤0.01% | 3569 |
|
|
2015
Q3 | – | Sell |
-7
| Closed | -$2K | – | 5287 |
|
|
2015
Q2 | $2K | Sell |
7
-43
| -86% | -$13K | ﹤0.01% | 4691 |
|
|
2015
Q1 | $14K | Buy |
50
+21
| +72% | +$9.07K | ﹤0.01% | 4043 |
|
|
2014
Q4 | $12K | Buy |
29
+15
| +107% | +$4.76K | ﹤0.01% | 4164 |
|
|
2014
Q3 | $5K | Sell |
14
-15
| -52% | -$4.4K | ﹤0.01% | 4738 |
|
|
2014
Q2 | $10K | Buy |
+29
| New | +$11.4K | ﹤0.01% | 4526 |
|
Other funds holding DMK
Group One Trading's DMK Position: Q1 2024 in Review
Group One Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 94 shares — an estimated $66 sold.
Group One Trading first reported a position in DMK in Q1 2014 and held it in 27 quarters. The position peaked at $535K in Q2 2017. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- Group One Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 94 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $66.
- Group One Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 27 quarters.
- Group One Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $535K in Q2 2017.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.